Yiling Yu

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 1

Top Topics

Hodgkin Lymphoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Gang An, Daobin Zhou, Shu Cheng, Keshu Zhou, Jianyong Li, Jian-Feng Zhou, Liping Xie, Jie Jin, Liye Zhong, Lingzhi Yan, Haiyi Guo, Chenmu Du, Jinhua Zhong, Yiling Yu, Binghao Wu, Lugui Qiu
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)